Characterization of hydrogel biomaterials and their interaction with components of the human tear film

水凝胶生物材料的表征及其与人泪膜成分的相互作用

基本信息

  • 批准号:
    227593-2010
  • 负责人:
  • 金额:
    $ 2.91万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2012
  • 资助国家:
    加拿大
  • 起止时间:
    2012-01-01 至 2013-12-31
  • 项目状态:
    已结题

项目摘要

Biomaterials are materials of natural or artificial origin that can mimic, store, or come into close contact with living biological cells or fluids. Biomaterials have exhibited steady growth over the past half century, particularly in the areas of medicine, biology, chemistry, pharmacy and materials science. Some examples of biomaterials include heart valves, blood vessels, artificial joint replacements, breast implants, intraocular lens (IOL) implants, and contact lenses (CL), of which the latter two are among the most widely used. Over 140 million people worldwide wear contact lenses (CL), of which 3 million reside in Canada. Approximately 90% of CL wearers use soft, hydrogel lenses, which are typically replaced after being used for 1 day to 1 month. Each year, 250,000 cataract extractions are performed in Canada, of which over 95% will have an IOL implant inserted. Thus, a rough calculation would suggest that each year in Canada alone, some 32 million new hydrogel CLs or IOLs are used by patients. These materials come into direct contact with the tear film on the surface of the eye or the aqueous humour within the eye, which are highly complex fluids containing a wide variety of proteins, lipids, ions, growth factors, metabolites and electrolytes. Once exposed to these fluids, CLs and IOLs deposit various components, some of which may induce inflammatory responses. Obtaining a greater understanding of the quantity and location of various deposited components will help to further our understanding of the development of next generation ocular biomaterials. While development of methods to examine protein and lipid interactions with hydrogel biomaterials would obviously be of interest to ocular biomaterial researchers, such methods would be applicable to the general biomaterials arena. This project will use a number of unique analytical techniques to characterise the surface of novel and commercially-available hydrogel contact lens and IOL materials and to investigate their interaction with components of the tear film and aqueous humour of the inner eye. It will specifically look at protein and lipid deposition, to attempt to provide materials that have better in vivo performance.
生物材料是天然或人工来源的材料,可以模拟,储存或与活的生物细胞或液体密切接触。生物材料在过去的半个世纪中呈现出稳定的增长,特别是在医学、生物学、化学、药学和材料科学领域。生物材料的一些实例包括心脏瓣膜、血管、人工关节置换物、乳房植入物、眼内透镜(IOL)植入物和接触透镜(CL),其中后两者是最广泛使用的。全球有超过1.4亿人佩戴隐形眼镜,其中300万人居住在加拿大。大约90%的CL配戴者使用柔软的水凝胶镜片,通常在使用1天至1个月后更换。加拿大每年进行25万例白内障摘除术,其中95%以上将植入IOL植入物。因此,粗略计算表明,仅在加拿大,每年患者使用约3200万个新的水凝胶CL或IOL。这些物质与眼睛表面的泪膜或眼内的房水直接接触,这些物质是含有各种蛋白质、脂质、离子、生长因子、代谢物和电解质的高度复杂的流体。一旦暴露于这些液体,CL和IOL存款各种成分,其中一些可能诱导炎症反应。获得对各种沉积组分的数量和位置的更好理解将有助于我们进一步理解下一代眼部生物材料的发展。虽然研究蛋白质和脂质与水凝胶生物材料相互作用的方法的开发显然会引起眼部生物材料研究人员的兴趣,但这种方法将适用于一般生物材料竞技场。该项目将使用许多独特的分析技术,对新型和市售水凝胶接触透镜和IOL材料的表面进行分析,并研究其与泪膜和内眼房水成分的相互作用。它将特别关注蛋白质和脂质沉积,以试图提供具有更好体内性能的材料。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jones, Lyndon其他文献

Variability of the analysis of the tear meniscus height by optical coherence tomography
  • DOI:
    10.1097/opx.0b013e3181560ba8
  • 发表时间:
    2007-09-01
  • 期刊:
  • 影响因子:
    1.4
  • 作者:
    Bitton, Etty;Keech, Adam;Jones, Lyndon
  • 通讯作者:
    Jones, Lyndon
CLEAR-Contact lens wettability, cleaning, disinfection and interactions with tears
  • DOI:
    10.1016/j.clae.2021.02.004
  • 发表时间:
    2021-03-25
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Willcox, Mark;Keir, Nancy;Jones, Lyndon
  • 通讯作者:
    Jones, Lyndon
In Vitro and In Vivo Evaluation of Novel Ciprofloxacin-Releasing Silicone Hydrogel Contact Lenses
Lipid deposition on contact lenses in symptomatic and asymptomatic contact lens wearers
  • DOI:
    10.1016/j.clae.2020.05.006
  • 发表时间:
    2021-01-05
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Omali, Negar Babaei;Subbaraman, Lakshman. N.;Jones, Lyndon
  • 通讯作者:
    Jones, Lyndon
Development of Mucoadhesive Drug Delivery System Using Phenylboronic Acid Functionalized Poly(D,L-lactide)-b-Dextran Nanoparticles
  • DOI:
    10.1002/mabi.201200216
  • 发表时间:
    2012-12-01
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Liu, Shengyan;Jones, Lyndon;Gu, Frank X.
  • 通讯作者:
    Gu, Frank X.

Jones, Lyndon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jones, Lyndon', 18)}}的其他基金

Biomaterials to Reduce Ocular Surface Inflammatory Response
减少眼表炎症反应的生物材料
  • 批准号:
    RGPIN-2017-03795
  • 财政年份:
    2021
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Discovery Grants Program - Individual
Biomaterials to Reduce Ocular Surface Inflammatory Response
减少眼表炎症反应的生物材料
  • 批准号:
    RGPIN-2017-03795
  • 财政年份:
    2020
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Discovery Grants Program - Individual
Biomaterials to Reduce Ocular Surface Inflammatory Response
减少眼表炎症反应的生物材料
  • 批准号:
    RGPIN-2017-03795
  • 财政年份:
    2019
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Discovery Grants Program - Individual
Biomaterials to Reduce Ocular Surface Inflammatory Response
减少眼表炎症反应的生物材料
  • 批准号:
    RGPIN-2017-03795
  • 财政年份:
    2018
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Discovery Grants Program - Individual
Biomaterials to Reduce Ocular Surface Inflammatory Response
减少眼表炎症反应的生物材料
  • 批准号:
    RGPIN-2017-03795
  • 财政年份:
    2017
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Discovery Grants Program - Individual
Cytation Cell Imaging Multi-Mode Reader
Cytation 细胞成像多模式读取器
  • 批准号:
    RTI-2017-00133
  • 财政年份:
    2016
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Research Tools and Instruments
Characterization of Ocular Biomaterial Uptake & Release
眼部生物材料吸收的表征
  • 批准号:
    RGPIN-2016-03887
  • 财政年份:
    2016
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Discovery Grants Program - Individual
Multiplexed Immunoassay Platform to Quantify Cytokines in Biological Samples
用于量化生物样品中细胞因子的多重免疫分析平台
  • 批准号:
    472311-2015
  • 财政年份:
    2014
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Research Tools and Instruments - Category 1 (<$150,000)
Characterization of hydrogel biomaterials and their interaction with components of the human tear film
水凝胶生物材料的表征及其与人泪膜成分的相互作用
  • 批准号:
    227593-2010
  • 财政年份:
    2014
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Discovery Grants Program - Individual
Characterization of hydrogel biomaterials and their interaction with components of the human tear film
水凝胶生物材料的表征及其与人泪膜成分的相互作用
  • 批准号:
    227593-2010
  • 财政年份:
    2013
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Discovery Grants Program - Individual

相似国自然基金

rSC-EXO/NGF/Li-hydrogel调控神经-骨免疫成骨修复股骨头坏死研究
  • 批准号:
    82372392
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于仿生矿化法构建氢离子捕获的炎症调节性水凝胶微球在卒中治疗中的研究
  • 批准号:
    82372120
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
炎症响应性Hydrogel/ECM复合支架负载纳米酶恢复ROS稳态及其诱导瓣膜组织原位再生研究
  • 批准号:
    32371421
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Multiscale hydrogel biomaterials-enabled 3D modeling of cancer drug resistance
基于多尺度水凝胶生物材料的癌症耐药性 3D 建模
  • 批准号:
    10639167
  • 财政年份:
    2023
  • 资助金额:
    $ 2.91万
  • 项目类别:
Engineering a vascularized macroencapsulation device for diabetes cellular therapy
设计用于糖尿病细胞治疗的血管化大封装装置
  • 批准号:
    469955
  • 财政年份:
    2022
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Operating Grants
Engineering injectable cold atmospheric plasma-preserved hydrogel to treat breast cancer
工程可注射冷常压等离子体保存水凝胶治疗乳腺癌
  • 批准号:
    463187
  • 财政年份:
    2022
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Operating Grants
Engineering an affibody-functionalized hydrogel for the controlled release of insulin-like growth factor 1 (IGF-1)
设计用于控制释放胰岛素样生长因子 1 (IGF-1) 的亲和体功能化水凝胶
  • 批准号:
    485903
  • 财政年份:
    2022
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Studentship Programs
Engineering injectable cold atmospheric plasma-preserved hydrogel to treat breast cancer
工程可注射冷常压等离子体保存水凝胶治疗乳腺癌
  • 批准号:
    455833
  • 财政年份:
    2021
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Operating Grants
Hybrid Hydrogel Biomaterials Comprising Clickable Decellularized Extracellular Matrix for Engineering Dynamic 3D Models of Fibrosis
包含可点击脱细胞细胞外基质的混合水凝胶生物材料,用于工程纤维化动态 3D 模型
  • 批准号:
    10224335
  • 财政年份:
    2020
  • 资助金额:
    $ 2.91万
  • 项目类别:
Hybrid Hydrogel Biomaterials Comprising Clickable Decellularized Extracellular Matrix for Engineering Dynamic 3D Models of Fibrosis
包含可点击脱细胞细胞外基质的混合水凝胶生物材料,用于工程纤维化动态 3D 模型
  • 批准号:
    10026363
  • 财政年份:
    2020
  • 资助金额:
    $ 2.91万
  • 项目类别:
CAREER: Spatiotemporally addressable hydrogel biomaterials as tools for investigating fibroblast mechanobiology
职业:时空可寻址水凝胶生物材料作为研究成纤维细胞力学生物学的工具
  • 批准号:
    1941401
  • 财政年份:
    2020
  • 资助金额:
    $ 2.91万
  • 项目类别:
    Continuing Grant
Hybrid Hydrogel Biomaterials Comprising Clickable Decellularized Extracellular Matrix for Engineering Dynamic 3D Models of Fibrosis
包含可点击脱细胞细胞外基质的混合水凝胶生物材料,用于工程纤维化动态 3D 模型
  • 批准号:
    10454853
  • 财政年份:
    2020
  • 资助金额:
    $ 2.91万
  • 项目类别:
Hybrid Hydrogel Biomaterials Comprising Clickable Decellularized Extracellular Matrix for Engineering Dynamic 3D Models of Fibrosis
包含可点击脱细胞细胞外基质的混合水凝胶生物材料,用于工程纤维化动态 3D 模型
  • 批准号:
    10661783
  • 财政年份:
    2020
  • 资助金额:
    $ 2.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了